Viewing Study NCT00138151


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-02-02 @ 4:09 AM
Study NCT ID: NCT00138151
Status: TERMINATED
Last Update Posted: 2013-11-20
First Post: 2005-08-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
Sponsor: University of Medicine and Dentistry of New Jersey
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent cervical cancer View
None stage IVB cervical cancer View